These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 11861393

  • 1. Targeted inactivation of p53 in human cells does not result in aneuploidy.
    Bunz F, Fauth C, Speicher MR, Dutriaux A, Sedivy JM, Kinzler KW, Vogelstein B, Lengauer C.
    Cancer Res; 2002 Feb 15; 62(4):1129-33. PubMed ID: 11861393
    [Abstract] [Full Text] [Related]

  • 2. Inactivation of p53 results in high rates of homologous recombination.
    Mekeel KL, Tang W, Kachnic LA, Luo CM, DeFrank JS, Powell SN.
    Oncogene; 1997 Apr 17; 14(15):1847-57. PubMed ID: 9150391
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Development of rhabdomyosarcoma in HER-2/neu transgenic p53 mutant mice.
    Nanni P, Nicoletti G, De Giovanni C, Croci S, Astolfi A, Landuzzi L, Di Carlo E, Iezzi M, Musiani P, Lollini PL.
    Cancer Res; 2003 Jun 01; 63(11):2728-32. PubMed ID: 12782574
    [Abstract] [Full Text] [Related]

  • 5. Induction of centrosome amplification and chromosome instability in human bladder cancer cells by p53 mutation and cyclin E overexpression.
    Kawamura K, Izumi H, Ma Z, Ikeda R, Moriyama M, Tanaka T, Nojima T, Levin LS, Fujikawa-Yamamoto K, Suzuki K, Fukasawa K.
    Cancer Res; 2004 Jul 15; 64(14):4800-9. PubMed ID: 15256449
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The role of thymidylate synthase induction in modulating p53-regulated gene expression in response to 5-fluorouracil and antifolates.
    Longley DB, Boyer J, Allen WL, Latif T, Ferguson PR, Maxwell PJ, McDermott U, Lynch M, Harkin DP, Johnston PG.
    Cancer Res; 2002 May 01; 62(9):2644-9. PubMed ID: 11980662
    [Abstract] [Full Text] [Related]

  • 9. The p53 tumor suppressor gene and nuclear protein: basic science review and relevance in the management of bladder cancer.
    Smith ND, Rubenstein JN, Eggener SE, Kozlowski JM.
    J Urol; 2003 Apr 01; 169(4):1219-28. PubMed ID: 12629332
    [Abstract] [Full Text] [Related]

  • 10. Analysis of p53 status in human cell lines using a functional assay in yeast: detection of new non-sense p53 mutation in codon 124.
    Smardová J, Pavlová S, Svitáková M, Grochová D, Ravcuková B.
    Oncol Rep; 2005 Oct 01; 14(4):901-7. PubMed ID: 16142349
    [Abstract] [Full Text] [Related]

  • 11. Extensive chromosomal instability in Rad51d-deficient mouse cells.
    Smiraldo PG, Gruver AM, Osborn JC, Pittman DL.
    Cancer Res; 2005 Mar 15; 65(6):2089-96. PubMed ID: 15781618
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Further studies on the arrest of cell proliferation in tumor cells at the invading front of colonic adenocarcinoma.
    Rubio CA.
    J Gastroenterol Hepatol; 2007 Nov 15; 22(11):1877-81. PubMed ID: 17914963
    [Abstract] [Full Text] [Related]

  • 14. Mutations in Apc and p53 synergize to promote mammary neoplasia.
    Méniel V, Hay T, Douglas-Jones A, Sansom OJ, Clarke AR.
    Cancer Res; 2005 Jan 15; 65(2):410-6. PubMed ID: 15695381
    [Abstract] [Full Text] [Related]

  • 15. Impact of p53 knockout and topotecan treatment on gene expression profiles in human colon carcinoma cells: a pharmacogenomic study.
    Daoud SS, Munson PJ, Reinhold W, Young L, Prabhu VV, Yu Q, LaRose J, Kohn KW, Weinstein JN, Pommier Y.
    Cancer Res; 2003 Jun 01; 63(11):2782-93. PubMed ID: 12782583
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. High incidence of protein-truncating TP53 mutations in BRCA1-related breast cancer.
    Holstege H, Joosse SA, van Oostrom CT, Nederlof PM, de Vries A, Jonkers J.
    Cancer Res; 2009 Apr 15; 69(8):3625-33. PubMed ID: 19336573
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. p53 apoptotic response to DNA damage dependent on bcl2 but not bax in head and neck squamous cell carcinoma lines.
    Crowe DL, Sinha UK.
    Head Neck; 2006 Jan 15; 28(1):15-23. PubMed ID: 16302195
    [Abstract] [Full Text] [Related]

  • 20. Lymphoma development in Bax transgenic mice is inhibited by Bcl-2 and associated with chromosomal instability.
    Luke JJ, Van De Wetering CI, Knudson CM.
    Cell Death Differ; 2003 Jun 15; 10(6):740-8. PubMed ID: 12761582
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.